CDC Situation Awareness - CDC Polio Response
The Situation Awareness Section's mission is to improve Public Health response and situation awareness by integrating and managing critical information, implementing knowledge management capabilities and processes to support CDC emergency response operations.
On December 2, 2011, CDC Director Thomas R. Frieden, MD, MPH, activated CDC's Emergency Operations Center to strengthen the agency's partnership engagement through the Global Polio Eradication Initiative (GPEI), which is committed to completing the eradication of polio.
The Situation Awareness Section which is part of the CDC's Emergency Operations Center, is committed to this activation by strengthen Public Health information sharing between CDC and its partners in monitoring, analyzing, and developing critical information to support the polio response and to produce data, actionable information, and visualization information products supporting the CDC Polio Response.
- CDC Polio Response
Learn about CDC's Polio Response working as a partner of the Global Polio Eradication Initiative.
- Global Polio Eradication Initiative
a partnership of the U.S. Centers for Disease Control and Prevention, UNICEF, the World Health Organization, and Rotary International; spearheading an effort to support country governments to immunize every child against polio until transmission stops and the world is polio-free.
- Focus Countries
Polio remains endemic in three countries – Afghanistan, Nigeria and Pakistan – with further countries known to have (Angola, Chad and Democratic Republic of the Congo) or suspected of having re-established transmission of poliovirus.
- Partner Resources
CDC Polio Response resources include Centers for Disease Control and Prevention, PAHO, WHO, USAID, and various working groups.
Logistic and Base Maps of select countries
- Page last reviewed: February 26, 2014
- Page last updated:February 26, 2014
- Content source: Division of Emergency Operations (DEO), Office of Public Health Preparedness and Response (OPHPR)